Search for: "Novartis Pharmaceuticals Inc"
Results 61 - 80
of 393
Sorted by Relevance
|
Sort by Date
4 Mar 2010, 3:28 pm
., and Novartis Pharmaceuticals, Inc.). [read post]
6 Mar 2018, 2:10 pm
We are doing this review because it was during April 2013 that Novartis Pharmaceuticals Canada Inc. took these actions: Sent a so-called "Dear Doctor" letter in Canada (but not the US) warning about some serious side effects associated with Tasigna; and, Issued a Tasigna drug label change in Canada (but not the US) with new information concerning those Tasigna side effects. [read post]
4 May 2010, 10:29 pm
According to DOJ’s press release: Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation have agreed to pay $72.5 million to resolve civil False Claims Act allegations arising from the marketing of the cystic fibrosis drug TOBI, the Justice Department announced today. [read post]
15 May 2011, 8:55 pm
• Defendant: Teva Pharmaceuticals USA Inc. [read post]
15 Apr 2019, 7:19 pm
Par Pharmaceutical Inc., Nos. 14-1289-RGA, 14-1494-RGA, 15-0078-RGA (D. [read post]
2 Feb 2009, 11:30 am
Park City 3 & 4 Apts., Inc. [read post]
7 Dec 2018, 2:23 pm
The outcome was reversal; Novartis wins:Novartis Pharmaceuticals Corporation and NovartisAG (collectively, Novartis) appeal the district court’sdecision to invalidate U.S. [read post]
12 Apr 2017, 8:44 am
” Synopsys, Inc. v. [read post]
22 May 2017, 9:22 am
Noven Pharmaceuticals, Inc., which affirmed the Patent Trial and Appeal Board (PTAB) invalidation of claims in related inter partes review (IPR) proceedings. [read post]
21 Jun 2022, 2:18 pm
Court of Appeals for the Federal Circuit issued a precedential decision in Novartis Pharmaceuticals Corp. v. [read post]
23 May 2015, 10:24 pm
Two recent decisions issued by the Australian Patent Office address the requirements for extending the term of a patent encompassing a pharmaceutical substance ‘when produced by a process that involves the use of recombinant DNA technology’: ImmunoGen, Inc. [2014] APO 88 and Novartis Vaccines and Diagnostics S.r.l. [2015] APO 2.What is interesting about both these cases is that, while recombinant DNA techniques are employed in manufacturing the… [read post]
10 Jan 2012, 3:22 pm
Novartis Consumer Health, Inc. has issued a recall on several popular over-the-counter medications including Excedrin, NoDoz, Bufferin, and Gas-X due to a possible manufacturing mix-up. [read post]
15 Jun 2012, 11:20 am
Novartis Pharmaceuticals Corp., No. [read post]
27 Feb 2018, 9:12 am
Relevant parts of this April 9, 2013 letter from Novartis Pharmaceuticals Canada Inc. are set forth below: Dear Healthcare Professional: Subject: Updated information regarding the possible risk of developing atherosclerosis-related diseases with the use of TASIGNA* (nilotinib) Novartis Pharmaceuticals Canada Inc. [read post]
22 Feb 2019, 3:48 am
Novartis AG v. [read post]
10 Oct 2016, 12:40 pm
Tasigna (nilotinib) -- Novartis Pharmaceuticals Canada Inc. [read post]
23 May 2022, 8:02 am
“Novartis’ DQ Bid Sinks In Gilenya Row” — “A federal judge in Delaware has rejected a legal effort to prevent a Washington, D.C., patent lawyer from representing an Indian pharmaceutical company in a patent fight with Novartis over the blockbuster multiple sclerosis drug Gilenya. [read post]
14 May 2019, 11:24 am
USA, Inc., 566 F.3d 989, 994(Fed. [read post]
24 May 2012, 12:02 pm
Abbott Laboratories Inc. [read post]
26 Jun 2007, 10:48 pm
• Sandoz Inc. of New Jersey (with subsidiaries Geneva Pharmaceuticals Inc., Novartis Pharmaceuticals Inc., Eon Labs and Apothecon Inc.) [read post]
